The GC-MS metabolomics signature in patients with fibromyalgia syndrome directs to dysbiosis as an aspect contributing factor of FMS pathophysiology
Publication year
2019Source
Metabolomics, 15, 4, (2019), pp. 54ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Laboratory Medicine
Journal title
Metabolomics
Volume
vol. 15
Issue
iss. 4
Page start
p. 54
Subject
Radboudumc 3: Disorders of movement DCMN: Donders Center for Medical NeuroscienceThis item appears in the following Collection(s)
- Academic publications [205084]
- Faculty of Medical Sciences [81053]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.